Novartis AG (NVSEF)
OTCMKTS · Delayed Price · Currency is USD
150.86
0.00 (0.00%)
Mar 18, 2026, 9:30 AM EST
Novartis AG Employees
Novartis AG had 75,267 employees as of December 31, 2025. The number of employees decreased by 616 or -0.81% compared to the previous year.
Employees
75,267
Change (1Y)
-616
Growth (1Y)
-0.81%
Revenue / Employee
$752,973
Profits / Employee
$185,792
Market Cap
279.88B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 75,267 | -616 | -0.81% |
| Dec 31, 2024 | 75,883 | -174 | -0.23% |
| Dec 31, 2023 | 76,057 | -25,646 | -25.22% |
| Jun 30, 2023 | 103,000 | -5,000 | -4.63% |
| Mar 31, 2023 | 103,000 | -7,000 | -6.36% |
| Dec 31, 2022 | 101,703 | -2,620 | -2.51% |
| Sep 30, 2022 | 108,000 | 0 | - |
| Jun 30, 2022 | 108,000 | -1,000 | -0.92% |
| Mar 31, 2022 | 110,000 | 0 | - |
| Dec 31, 2021 | 104,323 | -1,471 | -1.39% |
| Sep 30, 2021 | 108,000 | -2,000 | -1.82% |
| Jun 30, 2021 | 109,000 | -1,000 | -0.91% |
| Mar 31, 2021 | 110,000 | 1,000 | 0.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Glass House Brands | 374 |
| Vaxart | 105 |
| Silence Therapeutics | 88 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Tian'an Technology Group | 8 |
Novartis AG News
- 2 hours ago - US FDA flags seizure risk with certain Parkinson's drugs, seeks label warnings - Reuters
- 12 hours ago - Novartis to Buy Breast-Cancer Drug From Synnovation for Up to $3 Billion - WSJ
- 12 hours ago - Novartis to buy breast cancer drug candidate from Synnovation - Reuters
- 12 hours ago - Novartis to Acquire Synnovation Therapeutics' Pan-Mutant Selective PI3Kα Inhibitor Program - Business Wire
- 12 hours ago - Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline - GlobeNewsWire
- 2 days ago - TrumpRx lists many medicines at prices higher than paid in UK - Reuters
- 3 days ago - Big drugmakers must face US overcharge claims on medications for low-income patients - Reuters
- 3 days ago - Novartis Raises $11 Billion Bond to Fund $12 Billion Avidity Deal - GuruFocus